The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.

Abstract excerpt

Prostate cancer is a leading cause of global cancer-related death but attempts to improve diagnoses and develop novel therapies have been confounded by significant patient heterogeneity. In recent years, the application of next-generation sequencing to hundreds of prostate tumours has defined novel molecular subtypes and characterized extensive genomic aberration underlying disease initiation and progression. It...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA Copy Number Variations
• Share to Gene Fusion